Palantir Technologies is broadly rated a Hold by analysts for 2026, with just four of 25 covering analysts recommending a Buy. The consensus 12-month price target of $188 represents only a low single-digit percentage upside from current levels, reflecting tempered expectations despite 135% share gains in 2025. Revenue growth is expected to moderate to mid-teens quarterly expansion, and recurring subscription fees underpin 80.8% gross margins, but the stock’s lack of projected near-term upside has kept the majority of analysts on the sidelines.

Investors have grown concerned over Palantir’s valuation, which trades at approximately 175 times forward FY2026 earnings—second only to one other S&P 500 member. With a price-to-earnings-to-growth ratio near 2.9, Palantir’s valuation implies several years of growth baked into the share price. By contrast, software peers with similar growth profiles trade at PEG ratios closer to 1.0, highlighting Palantir’s premium and raising questions about upside potential until revenue growth materially accelerates or margins expand further.

In December 2025, Representative Jonathan Jackson disclosed a purchase of Palantir shares valued between $15,001 and $50,000, drawing scrutiny due to his seat on the House Foreign Affairs Committee. Palantir derives a significant portion of its revenue from U.S. federal agencies, including defense and intelligence, making any lawmaker trading its stock sensitive. The transaction complied with disclosure rules, but it reignited debate over congressional stock ownership in sectors where members influence policy and contract awards.